Case File
efta-02275302DOJ Data Set 11OtherEFTA02275302
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02275302
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
m
m
From:
Sent
T Ur
Subject
Fw: Catching Up
Hi Lesley,
:48 PM
I hope you're well! It's been a while since I was in touch! I emailed Jeffrey and Rich last night but
wasn't sure that they still use the email addresses that I have. Thank you for forwarding this onto
to them if you can.
I hope to see you soon! My cell is:
f you ever need to reach me.
all the very best,
gmail.com>;
Sent: Wednesday. January 16, 2019, 11:22:06 PM EST
Subject: Catching Up
Dear Jeffrey
I hope you've been well. I wanted to update you on what I've been up to for the last two years. I
was also hoping to talk with you to see if I might use the foundation's Lexington office conference
room from time to time for my work and what I could provide in exchange for that. I am ccling
Rich because I'm not sure if you still use this email?
EFTA_R1_01089030
EFTA02275302
Since working for your foundation, I continued to publish as a journalist writing mostly about
genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business
development for labs that have reversed age-driven or degenerative diseases. Most of the
therapies are genetic vectors, and have to show remarkable results at the mouse level and beyond.
Regenerative medicine is a rapidly evolving field, and one that forces the medical industry to shift
their focus from addressing symptoms of disease to fundamental evolutionary shortfalls.
So far, I placed a genetic vector at the National Institute of Medicine in France (that reversed
glaucoma in mice using the neuroglobin gene) under formal licence review with a publicly traded
pharma group here in the US. And I am collaborating with a lab at the University of Pittsburgh
that has reversed cirrhosis/ end stage liver disease in rats using the master transcription gene in
hepatocytes. The concept of the latter gene vector is really intriguing in that a master
transcription gene completely restored liver function by rebalancing genetic expression and thus
proteostasis.
While I don't really need an office at this point, I do need access to a conference room from time
to time and it would be hugely helpful if I could access the foundation's. If there was some work
that I could do for the foundation in exchange, I would be delighted to do that.
It would be wonderful to catch up with you as well.
all the best,
EFTA_R1_01089031
EFTA02275303
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
gmail.comPhone
2275302Phone
2275303Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.